Advanced NSCLC: Phase IV Trial Finds Combined Bevacizumab & Standard Chemo Safe, Relieving Earlier Concerns | Zendy

AI Assistant Blog Pricing

Open Access

Advanced NSCLC: Phase IV Trial Finds Combined Bevacizumab & Standard Chemo Safe, Relieving Earlier Concerns

Author(s) -

Heather Lindsey

Publication year - 2010

Publication title -

oncology times

Language(s) - Uncategorized

Resource type - Journals

eISSN - 1548-4688

pISSN - 0276-2234

DOI - 10.1097/01.cot.0000388582.61725.85

Subject(s) - bevacizumab , medicine , oncology , phase (matter) , chemotherapy , chemistry , organic chemistry

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Our institutional solutions Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Download on the

Discover

Explore

Copyright Knowledge E © 2026. All Rights Reserved.